Supernus Pharmaceuticals (SUPN) Non-cash Items (2011 - 2019)
Supernus Pharmaceuticals (SUPN) reported Non-cash Items of $2.6 million for Q1 2019, up 7.07% year-over-year from $2.4 million in Q1 2018, and up 37.87% quarter-over-quarter from $1.9 million in Q4 2018.
Supernus Pharmaceuticals (SUPN) Non-cash Items (2011 - 2019) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 9 years of Non-cash Items data on file, last reported at $2.6 million in Q1 2019.
- Non-cash Items for Q1 2019 came in at $2.6 million, up 7.07% year-over-year; the trailing twelve-month figure through Mar 2019 was $2.6 million (up 7.07% YoY), and the FY2018 annual result was $1.9 million, down 3.22% from the prior year.
- Non-cash Items grew to $2.6 million in Q1 2019 per SUPN's latest filing, from $1.9 million in the prior quarter.
- Over five years, Non-cash Items peaked at $108.5 million in Q4 2017 and troughed at $856008.0 in Q2 2015.
- A 5-year average of $11.8 million and a median of $1.9 million in 2018 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2015 and 2018: Non-cash Items soared 530.0% in 2015, then tumbled 98.26% in 2018.
- A 5-year view of Non-cash Items shows it stood at $12.6 million in 2015, then surged by 333.91% to $54.7 million in 2016, then jumped by 98.49% to $108.5 million in 2017, then plunged by 98.26% to $1.9 million in 2018, then jumped by 37.87% to $2.6 million in 2019.
- Business Quant data shows SUPN's Non-cash Items at $2.6 million in Q1 2019, $1.9 million in Q4 2018, and $1.9 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 2.61 Mn |
| Mar 31, 2019 | 2.61 Mn |
| Dec 31, 2018 | 1.89 Mn |
| Dec 31, 2018 | 1.89 Mn |
| Sep 30, 2018 | 1.89 Mn |
| Sep 30, 2018 | 1.89 Mn |
| Jun 30, 2018 | 1.95 Mn |
| Jun 30, 2018 | 1.95 Mn |
| Mar 31, 2018 | 2.43 Mn |
| Mar 31, 2018 | 2.43 Mn |
| Dec 31, 2017 | 108.52 Mn |
| Dec 31, 2017 | 108.52 Mn |
| Sep 30, 2017 | 1.96 Mn |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 2.16 Mn |
| Jun 30, 2017 | 2.16 Mn |
| Mar 31, 2017 | 2.24 Mn |
| Mar 31, 2017 | 2.24 Mn |
| Dec 31, 2016 | 54.67 Mn |
| Dec 31, 2016 | 54.67 Mn |